Biosimilars for psoriasis: preclinical analytical assessment to determine similarity

The challenge of indication extrapolation for infliximab biosimilars

(2014) Brian G. Feagan et al.   BIOLOGICALS

Biosimilars in rheumatology: the wind of change

(2013) Christian K Schneider   ANNALS OF THE RHEUMATIC DISEASES

The US Approach to Biosimilars

(2013) Begoña Calvo et al.   BIODRUGS

Nonclinical development of a biosimilar: the current landscape

(2013) Anita O’Connor et al.   Bioanalysis

Comparability and biosimilarity: considerations for the healthcare provider

(2012) Jaymi F. Lee et al.   CURRENT MEDICAL RESEARCH AND OPINION

Therapeutic Monoclonal Antibodies: Strategies and Challenges for Biosimilars Development

(2012) Begona Calvo et al.   CURRENT MEDICINAL CHEMISTRY

Analytical aspects of biosimilarity issues of protein drugs

(2012) Zsuzsanna Kálmán-Szekeres et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Biopharmaceuticals and biosimilars in psoriasis: What the dermatologist needs to know

(2012) Bruce E. Strober et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Interchangeability, immunogenicity and biosimilars

(2012) Hans C Ebbers et al.   NATURE BIOTECHNOLOGY

Acceptable changes in quality attributes of glycosylated biopharmaceuticals

(2011) Martin Schiestl et al.   NATURE BIOTECHNOLOGY

Biosimilars—why terminology matters

(2011) Martina Weise et al.   NATURE BIOTECHNOLOGY